Leeds spin-out Evocutis aims to remodel its business into either selling or licensing its LabSkin product after disappointing 2013.
Evocutis, a life sciences spin-out of Leeds University, is looking to either sell or license out its LabSkin product after poor performance in 2013. The decision comes on the back of a stalling in takeover talks in the last quarter of 2013 as the company looked to merge with another firm from the UK, US,…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
